232 related articles for article (PubMed ID: 17260012)
1. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.
Jönsson G; Dahl C; Staaf J; Sandberg T; Bendahl PO; Ringnér M; Guldberg P; Borg A
Oncogene; 2007 Jul; 26(32):4738-48. PubMed ID: 17260012
[TBL] [Abstract][Full Text] [Related]
2. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.
Stark M; Hayward N
Cancer Res; 2007 Mar; 67(6):2632-42. PubMed ID: 17363583
[TBL] [Abstract][Full Text] [Related]
4. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
[TBL] [Abstract][Full Text] [Related]
5. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
Jönsson G; Staaf J; Olsson E; Heidenblad M; Vallon-Christersson J; Osoegawa K; de Jong P; Oredsson S; Ringnér M; Höglund M; Borg A
Genes Chromosomes Cancer; 2007 Jun; 46(6):543-58. PubMed ID: 17334996
[TBL] [Abstract][Full Text] [Related]
6. Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines.
Hermans KG; van Alewijk DC; Veltman JA; van Weerden W; van Kessel AG; Trapman J
Genes Chromosomes Cancer; 2004 Mar; 39(3):171-84. PubMed ID: 14732919
[TBL] [Abstract][Full Text] [Related]
7. Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines.
Fadlelmola FM; Zhou M; de Leeuw RJ; Dosanjh NS; Harmer K; Huntsman D; Lam WL; Banerjee D
Mol Cancer; 2008 Jan; 7():2. PubMed ID: 18179710
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization.
Bastian BC; LeBoit PE; Hamm H; Bröcker EB; Pinkel D
Cancer Res; 1998 May; 58(10):2170-5. PubMed ID: 9605762
[TBL] [Abstract][Full Text] [Related]
9. Microarray comparative genomic hybridization detection of copy number changes in desmoplastic melanoma and malignant peripheral nerve sheath tumor.
Pryor JG; Brown-Kipphut BA; Iqbal A; Scott GA
Am J Dermatopathol; 2011 Dec; 33(8):780-5. PubMed ID: 21785329
[TBL] [Abstract][Full Text] [Related]
10. Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
Harbst K; Staaf J; Måsbäck A; Olsson H; Ingvar C; Vallon-Christersson J; Ringnér M; Borg A; Jönsson G
Melanoma Res; 2010 Oct; 20(5):381-91. PubMed ID: 20848731
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
12. "Lineage addiction" in human cancer: lessons from integrated genomics.
Garraway LA; Weir BA; Zhao X; Widlund H; Beroukhim R; Berger A; Rimm D; Rubin MA; Fisher DE; Meyerson ML; Sellers WR
Cold Spring Harb Symp Quant Biol; 2005; 70():25-34. PubMed ID: 16869735
[TBL] [Abstract][Full Text] [Related]
13. High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays.
Carr J; Bown NP; Case MC; Hall AG; Lunec J; Tweddle DA
Cancer Genet Cytogenet; 2007 Jan; 172(2):127-38. PubMed ID: 17213021
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.
Actor B; Cobbers JM; Büschges R; Wolter M; Knobbe CB; Lichter P; Reifenberger G; Weber RG
Genes Chromosomes Cancer; 2002 Aug; 34(4):416-27. PubMed ID: 12112531
[TBL] [Abstract][Full Text] [Related]
15. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma.
Yoshimoto T; Matsuura K; Karnan S; Tagawa H; Nakada C; Tanigawa M; Tsukamoto Y; Uchida T; Kashima K; Akizuki S; Takeuchi I; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2007 Dec; 213(4):392-401. PubMed ID: 17922474
[TBL] [Abstract][Full Text] [Related]
16. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines.
Roversi G; Pfundt R; Moroni RF; Magnani I; van Reijmersdal S; Pollo B; Straatman H; Larizza L; Schoenmakers EF
Oncogene; 2006 Mar; 25(10):1571-83. PubMed ID: 16247447
[TBL] [Abstract][Full Text] [Related]
18. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin.
Bastian BC; Kashani-Sabet M; Hamm H; Godfrey T; Moore DH; Bröcker EB; LeBoit PE; Pinkel D
Cancer Res; 2000 Apr; 60(7):1968-73. PubMed ID: 10766187
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization.
Roman E; Meza-Zepeda LA; Kresse SH; Myklebost O; Vasstrand EN; Ibrahim SO
Oncol Rep; 2008 Oct; 20(4):825-43. PubMed ID: 18813824
[TBL] [Abstract][Full Text] [Related]
20. Genomic alterations in primary cutaneous melanomas detected by metaphase comparative genomic hybridization with laser capture or manual microdissection: 6p gains may predict poor outcome.
Namiki T; Yanagawa S; Izumo T; Ishikawa M; Tachibana M; Kawakami Y; Yokozeki H; Nishioka K; Kaneko Y
Cancer Genet Cytogenet; 2005 Feb; 157(1):1-11. PubMed ID: 15676140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
